BridgeMD
New treatment option for Alzheimer Dementia
Official title Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
ClinicalTrials.gov ID: NCT07222280
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 90
You may be able to join if
- Ages 60 to 90 years old
- No prior diagnosis of dementia
- Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a...
You likely can't join if
- Age under 60 years
- Prior diagnosis of dementing illness or other organic etiology to cognitive impairment
The study team makes the final eligibility decision.
Where it's taking place
- Crossville, Tennessee, United States
- Harriman, Tennessee, United States
- Knoxville, Tennessee, United States
- Lenoir City, Tennessee, United States
- Oak Ridge, Tennessee, United States
- Sevierville, Tennessee, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Crossville, Tennessee, United States; Harriman, Tennessee, United States; Knoxville, Tennessee, United States; Lenoir City, Tennessee, United States; Oak Ridge, Tennessee, United States; Sevierville, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.